Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma. [electronic resource]
Producer: 20010329Description: 1637-44 p. digitalISSN:- 0008-5472
- Acid Phosphatase -- metabolism
- Animals
- Bone Marrow Cells -- cytology
- Bone Neoplasms -- metabolism
- COS Cells
- Carrier Proteins -- biosynthesis
- Cell Communication -- physiology
- Coculture Techniques
- Cyclooxygenase 2
- Female
- Glycoproteins -- pharmacology
- Humans
- Interleukin-1 -- biosynthesis
- Isoenzymes -- biosynthesis
- Membrane Glycoproteins -- biosynthesis
- Membrane Proteins
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Neoplasm Transplantation
- Neuroblastoma -- metabolism
- Osteoclasts -- drug effects
- Osteoprotegerin
- Prostaglandin-Endoperoxide Synthases -- biosynthesis
- RANK Ligand
- Receptor Activator of Nuclear Factor-kappa B
- Receptors, Cytoplasmic and Nuclear
- Receptors, Tumor Necrosis Factor
- Recombinant Proteins -- pharmacology
- Reverse Transcriptase Polymerase Chain Reaction
- Tartrate-Resistant Acid Phosphatase
- Transplantation, Heterologous
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.